Concepedia

Gerhard Hannig

GH

34

Publications

2.4K

Citations

22

H-Index

1991

Active since

Affiliations

Ironwood Pharmaceuticals (United States)(Current)

Harvard University

Tris Pharma (United States)

University of Oklahoma Health Sciences Center

Flinders University

Gerhard Hannig is an author at Ironwood Pharmaceuticals (United States) specializing in medicine, natural sciences, and molecular biology.

Top concepts

Publications per year

1991–2020

34

Publications

34

Strategies for optimizing heterologous protein expression in Escherichia coli

Gerhard Hannig, Savvas C. Makrides · Trends in biotechnology · 1998 · 485 citations

, , +2

Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate

Joel Castro, Andrea M. Harrington, Patrick A. Hughes et al. · Gastroenterology · 2013 · 285 citations · Full text

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

Robert Busby, Alexander P. Bryant, Wilmin Bartolini et al. · European Journal of Pharmacology · 2010 · 245 citations

, , +9

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

Alexander P. Bryant, Robert Busby, Wilmin Bartolini et al. · Life Sciences · 2010 · 221 citations

, , +8

Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Robert Busby, Marco M. Kessler, Wilmin Bartolini et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 132 citations

Rows per page

1–5 of 34